CLOs on the Move

Orbus Therapeutics

www.orbustherapeutics.com

 
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Abc For Health

Abc For Health is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ISS Solutions

ISS Solutions is a Langhorne, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AandD Weighing

A&D Weighing is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elevate ENT Partners

ELEVATE ENT Partners is a practice management support organization that provides private ear, nose, and throat (ENT) practices with the business support, capital, and resources they need to provide focused, quality care to their patients, grow their pr...

Harlan County Health System

Harlan County Health System is a Alma, NE-based company in the Healthcare, Pharmaceuticals, & Biotech sector.